dc.contributor.author
Camós Carreras, Anna
dc.contributor.author
Figueras Roca, Marc
dc.contributor.author
Dotti Boada, Marina
dc.contributor.author
Alcubierre, Rafel
dc.contributor.author
Casaroli Marano, Ricardo Pedro
dc.contributor.author
Muñoz, Esteban
dc.contributor.author
Sánchez Dalmau, Bernardo
dc.date.issued
2025-04-23T12:30:17Z
dc.date.issued
2025-04-23T12:30:17Z
dc.date.issued
2024-02-24
dc.date.issued
2025-04-23T12:30:17Z
dc.identifier
https://hdl.handle.net/2445/220547
dc.description.abstract
Spectral domain optical coherence tomography (SD-OCT) allows noninvasive measurements of retinal neuron layers. Here, we evaluate the relationship between clinical features and anatomical SD-OCT measurements in patients with spinocerebellar ataxia type 3 (SCA3) and how they change with time. A retrospective review was conducted on SCA3 patients. Clinical variables such as disease duration, number of CAG repeats, and the Scale for the Assessment and Rating of Ataxia (SARA) score were correlated with SD-OCT measurements, including retinal nerve fiber layer (RNFL) thickness, ganglion cell complex (GCC) thickness, macular volume (MV), and central macular thickness (CMT). Seventeen SCA3 patients with an average follow-up of 44.9 months were recruited. Clinical features with significant baseline correlations with SD-OCT measurements included disease duration (CMT r = - 0.590; GCC r = - 0.585), SARA score (CMT r = - 0.560; RNFL r = - 0.390), and number of CAG repeats (MV r = - 0.552; RNFL r = - 0.503; GCC r = - 0.493). The annual rate of change of the SARA score during follow-up was associated with that of both the MV (r = - 0.494; p = 0.005) and GCC thickness (r = - 0.454; p = 0.012). High disability (stages 2 and 3) was independently inversely associated with the annual change in MV (ß coefficient - 17.09; p = 0.025). This study provides evidence of an association between clinical features and objective anatomical measurements obtained by SD-OCT in SCA3 patients. MV and GCC thickness could serve as potential biomarkers of disease severity, as their rates of decrease seem to be related to a worsening in the SARA score. These findings highlight the potential of SD-OCT as a noninvasive tool for assessing disease severity and progression in SCA3 patients.<br /><br />
dc.format
application/pdf
dc.publisher
Springer Verlag
dc.relation
Reproducció del document publicat a: https://doi.org/10.1007/s12311-023-01634-1
dc.relation
The Cerebellum, 2024, vol. 23, num.4, p. 1348-1354
dc.relation
https://doi.org/10.1007/s12311-023-01634-1
dc.rights
cc by (c) Camós-Carreras, Anna et al., 2024
dc.rights
https://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
dc.subject
Tomografia de coherència òptica
dc.subject
Malalties neurodegeneratives
dc.subject
Optical coherence tomography
dc.subject
Neurodegenerative Diseases
dc.title
Progression of Retinal Ganglion Cell and Nerve Fiber Layer Loss in Spinocerebellar Ataxia 3 Patients
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion